Let's spread the word about Immunotherapy! Click to share this page with your community.

Upcoming Conferences

September 14, 20208:00 AM


2020 International Cancer Immunotherapy Conference takes place September 14-17, 2020, at the New York Hilton Midtown in New York City.

Past Conferences

September 25, 20198:00 AM

CICON 2019

The Fifth CRI-CIMT-EATI-AACR CICON takes place September 25-28, 2019, at Espace Grand Arche de la Défense in Paris, France.

May 14, 20198:30 AM

2019 Frontiers in Cancer Immunotherapy

This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.

February 06, 20197:30 AM

2019 Immuno-Oncology 360˚

CRI members receive a 20% off registration to the 5th annual Immuno-Oncology 360° in New York City. 

September 30, 20189:00 AM

2018 International Cancer Immunotherapy Conference

The fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, held in New York City, is devoted to exploring the latest research in cancer immunology and immunotherapy.

September 13, 20187:45 AM

Third Annual Rational Combinations 360°

Rational Combinations 360° is a comprehensive program providing exposure to the entire spectrum of research and development, addressing key aspects across all facets of combination immunotherapies.

April 26, 20189:00 AM

2018 Frontiers in Cancer Immunotherapy

This two-day scientific conference will convene experts in oncology and immunology to discuss emerging approaches, challenges, and opportunities faced in the rapidly evolving field of cancer immunotherapy.

February 07, 20187:45 AM

2018 Immuno-Oncology 360°

The fourth annual Immuno-Oncology 360° meeting will be held on February 7-9, 2018 at the Roosevelt Hotel, New York City.

September 06, 201712:00 PM


The Third Annual CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference will be hosted in Frankfurt, Germany for 2017.

June 28, 20177:30 AM

Second Annual Rational Combinations 360°

Industry and academic leaders address scientific, clinical, and business developments in immuno-oncology combination strategies to fight a wider range of cancers

February 01, 201710:00 AM

2017 Immuno-Oncology 360°

Designed by lead Advisors Dr. Axel Hoos (GSK) and Dr. James Gulley (NCI), the program provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated.

*Immunotherapy results may vary from patient to patient.